During a working visit of the President of Ukraine Volodymyr Zelenskyy to the United States of America, the Ministry of Health signed a Memorandum of Cooperation with the American company MSD. This was announced by Minister of Health Viktor Liashko.
“The Ministry of Health is interested in developing the potential of Ukraine’s healthcare system, and strengthening cooperation with MSD is strategic for Ukraine’s healthcare system, especially amid pandemic,” the Health Minister stressed.
It is a priority for the Ministry of Health to boost the supply of innovative medicines and immunobiological drugs on the Ukrainian market and to create opportunities for localization of their production in Ukraine on the basis of international partnership, which is one of the steps to pharmaceutical independence. The important tool in the localization of production is the adoption of the law on state support of projects with significant investments, the so-called “investment nannies” and the efficiency of the regulatory system in the circulation of medicines.
Cooperation with MSD on a mutually beneficial basis will enable Ukraine to treat patients with COVID-19 by providing innovative medicines.
“Ukraine would become one of the first countries in the world to receive innovative drugs against COVID-19 produced by MSD,” Viktor Liashko underlined. “We have learned lessons on the late signing of contracts for innovative immunobiological drugs from COVID-19, so now the team of the Ministry of Health is staying ahead. ”
MSD also expressed interest in assisting the Ministry of Health in conducting screening programs as part of the implementation of the President’s program “Healthy Ukraine”.